Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Solid Tumor × Injections × Clear all

Phase

Status

Sponsor Class

INDUSTRY 11 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Triple Negative Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Neuroendocrine Tumors 1 Intestinal Neoplasms 1 Hematopoietic Recovery 1 HER2 Low Breast Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Adenoma, Islet Cell 1

Interventions

apatinib 2 phosphorylethanolamine 1 fludarabine 1 camrelizumab 1 Interleukin-2 1 Injections 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04832204 2021-04-05

Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases

Beijing Hospital

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡